Infliximab Activity and Neutralizing Antibody
Order Name
Infliximab NAB
Test Number: 6905051
Revision Date 01/02/2020
Test Number: 6905051
Revision Date 01/02/2020
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Infliximab Activity and Neutralizing Antibody
|
Electrochemiluminescent Immunoassay |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 2 mL (1 mL) | Serum | Clot Activator SST | Frozen |
| Instructions | Notes: 1 mL (Note: This volume Does NOT allow for repeat testing). Specimen Type: Red-top tube or gel-barrier tube Specimen Storage: Frozen (preferred) or refrigerated Stability: Room temperature: 7 days Refrigerated: 7 days Frozen: 359 days Freeze/thaw cycle: stable x6 Specimen Collection: Serum must be separated from cells within 45 minutes of venipuncture. Send serum in a plastic transport tube. To avoid delays in turnaround time when requesting multiple test on frozen samples, PLEASE SUBMIT SEPARATE FROZEN SPECIMENS FOR EACH TEST REQUESTED. Special Instructions: Testing is performed at Esoterix Endocrinology Laboratory: ES#803870 Test includes Serial Monitoring. |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 5-10 days |
| Performing Labcorp Test Code | 503870 |
| Notes | Labcorp Test Code: 503870 |
| CPT Code(s) | 80230, 82397 |
| Lab Section | Reference Lab |